Gerard J. Criner, MD, FACP, FACCP, Director of the Temple Lung Center and Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University, spoke with WHYY about the use of artificial intelligence (AI) software, which advances lung screening and detection – all from a single low-dose CT scan. The AI software, which can help detect lung nodules, quantify emphysema, and analyze coronary artery calcification, does not dictate clinical decisions or make any final treatment calls, but is an aid that may allow clinicians to assess a condition more quickly and/or more thoroughly, predict risks, and explore treatment plans.